ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026
2 april, 14:00
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026
Zinzino group revenue increased with a total of 26 % in Q1 compared with the previous year.
The revenue in March for Zinzino's sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. Faun Pharma's external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year.
The group revenue increased with 26 % for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million.
Revenues were distributed as follows:
Regions, mSEK | 26-mar | 25-mar | Change | Q1 2026 | Q1 2025 | Change |
The Nordics | 27.1 | 26.6 | 2% | 77.7 | 77.1 | 1% |
Central Europe | 103.3 | 69.6 | 48% | 274.9 | 196.4 | 40% |
East Europe | 29.5 | 34.0 | -13% | 85.1 | 97.2 | -12% |
South & West Europe | 59.2 | 42.9 | 38% | 155.7 | 124.9 | 25% |
The Baltics | 10.3 | 9.4 | 10% | 29.2 | 28.7 | 2% |
North America | 80.2 | 56.1 | 43% | 188.7 | 110.3 | 71% |
South America | 4.3 | 0.6 | 617% | 11.8 | 2.3 | 413% |
Asia-Pacific | 25.9 | 24.6 | 5% | 66.8 | 65.8 | 2% |
Africa | 2.4 | 2.0 | 20% | 6.5 | 5.0 | 30% |
Zinzino | 342.2 | 265.8 | 29% | 896.4 | 707.7 | 27% |
Faun Pharma | 6.6 | 7.1 | -7% | 19.0 | 16.0 | 19% |
Zinzino Group | 348.8 | 272.9 | 28% | 915.4 | 723.7 | 26% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island.
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Zinzinois a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
Ämnen i artikeln
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026
2 april, 14:00
ZINZINO AB (PUBL): PRELIMINARY SALES REPORT Q1 2026
Zinzino group revenue increased with a total of 26 % in Q1 compared with the previous year.
The revenue in March for Zinzino's sales markets increased by 29% and amounted to SEK 342.2 (265.8) million. Faun Pharma's external sales decreased and amounted to SEK 6.6 (7.1) million. Overall, the Group increased revenues by 28% to SEK 348.8 (272.9) million compared with the previous year.
The group revenue increased with 26 % for Q1 2026 compared with the first quarter last year and amounted to SEK 915.4 (723.7) million.
Revenues were distributed as follows:
Regions, mSEK | 26-mar | 25-mar | Change | Q1 2026 | Q1 2025 | Change |
The Nordics | 27.1 | 26.6 | 2% | 77.7 | 77.1 | 1% |
Central Europe | 103.3 | 69.6 | 48% | 274.9 | 196.4 | 40% |
East Europe | 29.5 | 34.0 | -13% | 85.1 | 97.2 | -12% |
South & West Europe | 59.2 | 42.9 | 38% | 155.7 | 124.9 | 25% |
The Baltics | 10.3 | 9.4 | 10% | 29.2 | 28.7 | 2% |
North America | 80.2 | 56.1 | 43% | 188.7 | 110.3 | 71% |
South America | 4.3 | 0.6 | 617% | 11.8 | 2.3 | 413% |
Asia-Pacific | 25.9 | 24.6 | 5% | 66.8 | 65.8 | 2% |
Africa | 2.4 | 2.0 | 20% | 6.5 | 5.0 | 30% |
Zinzino | 342.2 | 265.8 | 29% | 896.4 | 707.7 | 27% |
Faun Pharma | 6.6 | 7.1 | -7% | 19.0 | 16.0 | 19% |
Zinzino Group | 348.8 | 272.9 | 28% | 915.4 | 723.7 | 26% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Island.
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-South America: Peru, Colombia
-Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge: marketing@zinzino.com
Zinzinois a global health tech company from Scandinavia, pioneering a new standard in personal health through advanced home health tests and scientifically proven nutritional supplements. Listed on the Nasdaq First North Premier Growth Market, the company’s test-based, personalized nutrition strategy empowers individuals to take charge of their long-term health with science-based insights and targeted solutions. Its third-party validated products are available through direct sales distributors in more than 100 markets worldwide. Zinzino’s headquarters are located in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.
Ämnen i artikeln
Rapporter
Analys
Rapporter
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
